Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

2017 Forecast – Hormone Refractory Prostate Cancer Global Market, Industry Size, Share, Analysis and Opportunities to 2023.

Thursday, March 9, 2017 4:55
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on Hormone Refractory Prostate Cancer Market. Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

A promising drug pipeline, evolving treatment patterns and augmented patient awareness are the factors that would largely drive the market growth. Further, untapped patient population in the Asia Pacific region would lead to a large uptake of these treatments.

Get Free Sample Report Of Hormone Refractory Prostate Cancer Market @ http://www.marketresearchstore.com/report/world-hormone-refractory-prostate-cancer-market-71675#RequestSample

On the other hand, premium pricing of HRPCA drugs, uncertain reimbursement policies and limited survival periods are likely to curtail the market growth.

Notably, physician’s reluctance towards adoption of these premium treatments would remain a key challenge for the leading innovators. However, the untapped non-metastatic CRPC market would open new avenues for the new and existing companies. Additionally, emerging economies with undiagnosed patient population and mounting prevalence would provide growth opportunities in future.

The market is expected to register substantial growth attributed to the strategies adopted by leading market players. One of the key strategies adopted is collaboration agreement. For instance, in 2009, Astellas Pharma Inc. entered into an agreement with Mediation, Inc. to co-develop and co-commercialize MDV3100 (now Xtandi) for the treatment of HRPCA.

Do Inquiry To Buy Report Of Hormone Refractory Prostate Cancer Market @ http://www.marketresearchstore.com/report/world-hormone-refractory-prostate-cancer-market-71675#InquiryForBuying

The Global HRPCA market segmentation is illustrated below:

HRPCA Market By Therapy Type

  • Chemotherapy
  • Cytotoxic Agents
  • Hormonal Therapy
  • Anti-Androgens
  • Immunotherapy
  • Radiation Therapy
  • Radio-Pharmaceuticals

HRPCA Market By Geography

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

About Market research Store

Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.